In this episode of Virtually Live, Shannon Rivkin covers Optiscan (OIL), ProMedicus (PME), and Creso Pharma Ltd. (CPH).
In this week’s show
- 0:24 – General market update
- 1:18 – Q1: Any thoughts on the doubling of Optiscan (OIL) in the last month and how active a role does a non-executive chair play?
- 4:54 – Q2: What does ProMedicus (PME) on market share buyback means for its share price over the next several months?
- 7:58 – Q3: How would you rate Creso Pharma Ltd (CPH) prospects in the short, medium, and long term, and is there any particular player in the medicinal cannabis industry you would prefer?
Listen to the audio version
New Educational Videos
Members should also watch out for the first of a new series of educational videos that Rivkin plans on producing. These videos will be 3 to-6 minutes in length. We don’t want to inundate members with emails, so you can opt in to receive emails when they are released or you can simply see them on the website. The first one is discussing the opening and closing rotations on the ASX and can be found through HERE.
Rivkin does not take into account your or anyone else’s personal situation in their market and stock commentary. Please keep this in mind when you are taking buy and sell decisions about any of these stocks that are mentioned in our Virtually Lives.
